AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 277 filers reported holding AVANOS MED INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $345 | -21.1% | 17,100 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $437 | -81.7% | 17,100 | -78.7% | 0.00% | -50.0% |
| Q1 2023 | $2,391 | +344.4% | 80,400 | +304.0% | 0.00% | +100.0% |
| Q4 2022 | $538 | -99.9% | 19,900 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $433,000 | -20.4% | 19,900 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $544,000 | -13.5% | 19,900 | +5.9% | 0.00% | 0.0% |
| Q1 2022 | $629,000 | -3.4% | 18,800 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $651,000 | +11.1% | 18,800 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $586,000 | -44.6% | 18,800 | -35.4% | 0.00% | -50.0% |
| Q2 2021 | $1,058,000 | +53.1% | 29,100 | +84.2% | 0.00% | +33.3% |
| Q1 2021 | $691,000 | -4.6% | 15,800 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $724,000 | -32.8% | 15,800 | -36.0% | 0.00% | -40.0% |
| Q2 2019 | $1,077,000 | -0.2% | 24,700 | -2.4% | 0.01% | 0.0% |
| Q1 2019 | $1,079,000 | +4.4% | 25,300 | +9.5% | 0.01% | 0.0% |
| Q4 2018 | $1,034,000 | -29.8% | 23,100 | +7.4% | 0.01% | -16.7% |
| Q3 2018 | $1,472,000 | – | 21,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 2,482,743 | $113,908,000 | 6.40% |
| RGM Capital, LLC | 1,984,455 | $91,047,000 | 3.97% |
| Cove Street Capital, LLC | 204,438 | $9,380,000 | 1.66% |
| Millrace Asset Group, Inc. | 41,200 | $1,890,000 | 1.32% |
| Phocas Financial Corp. | 142,037 | $6,516,000 | 1.00% |
| Champlain Investment Partners, LLC | 3,470,935 | $159,246,000 | 0.91% |
| HEARTLAND ADVISORS INC | 231,533 | $10,623,000 | 0.76% |
| CONFLUENCE INVESTMENT MANAGEMENT LLC | 481,042 | $22,070,000 | 0.33% |
| Wakefield Asset Management LLLP | 14,653 | $672,000 | 0.28% |
| S.A. Mason LLC | 6,527 | $299,000 | 0.25% |